79 FR 32 pg. 9243 - Office of the Director, National Institutes of Health; Notice of Meeting
Type: NOTICEVolume: 79Number: 32Page: 9243
Page: 9243FR document: [FR Doc. 2014-03395 Filed 2-14-14; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.),notice is hereby given of a meeting of the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to space available. Individualswho plan to attend and need special assistance, such as sign language interpretation or otherreasonable accommodations, should notify the Contact Person listed below in advance of themeeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: March 12, 2014.
Time: 9:30 a.m. to 3:30 p.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols and related data managementactivities. Please check the meeting agenda at OBA Meetings Page (availableat the following URL: http://oba.od.nih.gov/rdna_rac/rac_meetings.html ) for more information.
Place: National Institutes of Health,Rockledge II,Conference Room 9100,6701 Rockledge Drive,Bethesda, MD 20892.
Contact Person: Chris Nice,Program Assistant,Office of Biotechnology Activities,National Institutes of Health,6705 Rockledge Drive, Suite 750,Bethesda, MD 20892,301-496-9838, nicelc@mail.nih.gov.
Information is also available on the Institute's/Center's home page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any additional information for the meeting will be posted when available.
OMB's "Mandatory Information Requirements for Federal Assistance Program Announcements" (45 FR 39592, June 11, 1980) requires a statement concerning the official government programscontained in the Catalog of Federal Domestic Assistance. Normally NIH lists in itsannouncements the number and title of affected individual programs for the guidance of thepublic. Because the guidance in this notice covers virtually every NIH and Federal researchprogram in which DNA recombinant molecule techniques could be used, it has been determinednot to be cost effective or in the public interest to attempt to list these programs. Such a list wouldlikely require several additional pages. In addition, NIH could not be certain that every Federalprogram would be included as many Federal agencies, as well as private organizations, bothnational and international, have elected to follow the NIH Guidelines. In lieu of the individualprogram listing, NIH invites readers to direct questions to the information address above aboutwhether individual programs listed in the Catalog of Federal Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research TrainingAward; 93.22, Clinical Research Loan Repayment Program for Individuals from DisadvantagedBackgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, AcademicResearch Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome ResearchLoan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals fromDisadvantaged Backgrounds, National Institutes of Health, HHS)
Dated: February 12, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03395 Filed 2-14-14; 8:45 am]
BILLING CODE 4140-01-P